We observed that dual therapy induced a statistically significant increment of tumor‐infiltrating M‐MDSCs compared with the control group, while BRAFi and anti‐m‐VEGFA single therapy did not alter the presence of M‐MDSCs. The gene discussed is VEGFA; the disease is neoplasm.